Development of novel antibacterial peptides that kill resistant isolates.
about
Allosteric Coupling between the Lid and Interdomain Linker in DnaK Revealed by Inhibitor Binding StudiesFatty acyl benzamido antibacterials based on inhibition of DnaK-catalyzed protein folding.Screening for peptide drugs from the natural repertoire of biodiverse protein folds.Synergy among antibacterial peptides and between peptides and small-molecule antibiotics.Heat shock protein 70 (hsp70) as an emerging drug target.Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.Development of second generation peptides modulating cellular adiponectin receptor responses.A technology for developing synbodies with antibacterial activityComparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic BacteriaStress wars: the direct role of host and bacterial molecular chaperones in bacterial infection.Identification of immune genes and proteins involved in the response of bovine mammary tissue to Staphylococcus aureus infection.Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo.Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.Mechanism of Escherichia coli resistance to Pyrrhocoricin.Enzymatic hydrolyzed feather peptide, a welcoming drug for multiple-antibiotic-resistant Staphylococcus aureus: structural analysis and characterization.Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.In Vitro Antimicrobial Activity of Ethanolic Extract of Polish Propolis against Biofilm Forming Staphylococcus epidermidis Strains.Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl.Catechin Hydrate Augments the Antibacterial Action of Selected Antibiotics against Staphylococcus aureus Clinical Strains.Antibacterial Activity of Protocatechuic Acid Ethyl Ester on Staphylococcus aureus Clinical Strains Alone and in Combination with Antistaphylococcal Drugs.Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes.The effect of a probiotic strain (Lactobacillus acidophilus) on the plaque formation of oral Streptococci.Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs.Dimeric unnatural polyproline-rich peptides with enhanced antibacterial activity.Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro.Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs.Current challenges in peptide-based drug discovery.Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin.In vivo activity of mutacin B-Ny266.Cyclization of pyrrhocoricin retains structural elements crucial for the antimicrobial activity of the native peptide.Antibacterial Activity of the Non-Cytotoxic Peptide (p-BthTX-I)₂ and Its Serum Degradation Product against Multidrug-Resistant Bacteria.Identification of Novel Cytotoxic Peptide KENPVLSLVNGMF from Marine Sponge Xestospongia testudinaria, with Characterization of Stability in Human SerumAdvantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development
P2860
Q27653249-93EC3B9D-D9B1-4455-AE6A-6CE07925832BQ30319919-CAC3D616-8655-490E-9EF3-A12CCE74B815Q33233385-495C4954-4E3E-424D-A36A-E0040A86FC6AQ33593511-ED90178F-D0DF-4D43-806D-0D22D3CE36ACQ33956906-BB1F14E5-C23A-44AD-8AEB-5B8EB3CAB237Q34048086-0DF502F9-D561-4A05-9E81-4A24C4460A07Q34360125-2CA379CB-CDB4-4FF4-B8AD-5D114008CA62Q34570999-4560687D-9A45-4593-9741-5A8B92F53DDDQ35866086-6D94CAEE-E274-44DB-B263-8EB5D5CF0477Q36514519-A41DEA56-EB26-435E-B14A-DA7D6FC85ED1Q36725283-FE657211-D487-4372-9EF0-CC35261EB22DQ36740783-0E3AFDCF-359A-4425-8835-A5CABC61FE8FQ38805792-38916567-AE95-447B-B332-DAAD2CAF15F1Q38848631-D6ED519F-9908-4CCA-8C87-5E65A8542C7FQ38913239-1A19D939-5F11-4810-9484-A3A1429FD15AQ39376740-E73A8201-AE9C-4A86-A600-922ECD713C58Q40189760-BAC67DDC-C7C9-41A0-BC0C-94CC63CDAD11Q40750300-20836765-E020-4745-9D69-32F21CDDACB4Q40780542-86A28EEB-9D08-4358-9B91-B613097992DAQ41544791-E947A3B3-267F-476F-9748-501DFA572CECQ41823699-4C464A43-0446-41FE-96BA-E453F412CBF3Q41891422-123DC4C7-115D-430A-AC91-018FCD10356EQ41949708-3B6B32EE-C68A-42BD-81FA-24FF80CE745AQ41979383-6B1FD034-86A8-41E4-A134-621F775BAF57Q42139887-42E583EE-966D-4294-89E4-C1752AB4D9AEQ42216868-FB0572F9-96BB-45B5-8130-76555B97D91AQ42276953-C87A0B15-FBE3-46FE-A6D0-7D577D56636FQ42778271-FB493964-F271-443D-BB21-3F51D256E210Q44117220-A194FEF5-AD87-4ECC-BE6F-E2745416AA71Q46696994-58410CFA-84C5-414D-8472-51BB7FB109FAQ47867146-6B756CD9-A85C-49D1-9D2D-E2B824797CA0Q48348342-89B0EC26-405F-4612-B511-B246C500A9B9Q57657992-CAEADBA6-9379-47C8-948C-18F5B365D5EAQ58728409-6AAA5F01-3EE9-4010-9C0F-313E4BDB6991
P2860
Development of novel antibacterial peptides that kill resistant isolates.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Development of novel antibacterial peptides that kill resistant isolates.
@en
Development of novel antibacterial peptides that kill resistant isolates.
@nl
type
label
Development of novel antibacterial peptides that kill resistant isolates.
@en
Development of novel antibacterial peptides that kill resistant isolates.
@nl
prefLabel
Development of novel antibacterial peptides that kill resistant isolates.
@en
Development of novel antibacterial peptides that kill resistant isolates.
@nl
P2093
P1433
P1476
Development of novel antibacterial peptides that kill resistant isolates
@en
P2093
Barry A Condie
Elena S Lysenko
Laszlo Otvos
Mare Cudic
Zhi Q Xiang
P304
P356
10.1016/S0196-9781(02)00244-9
P577
2002-12-01T00:00:00Z